Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Non-cash Items (2019 - 2025)

Outlook Therapeutics (OTLK) has disclosed Non-cash Items for 4 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • Quarterly Non-cash Items fell 77.12% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, down 77.12% year-over-year, with the annual reading at $2.0 million for FY2025, N/A changed from the prior year.
  • Non-cash Items for Q4 2025 was $1.5 million at Outlook Therapeutics, down from $2.0 million in the prior quarter.
  • The five-year high for Non-cash Items was $6.5 million in Q4 2024, with the low at $1200.0 in Q2 2025.